Guggenheim Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.03M | Buy |
36,868
+2,588
| +8% | +$142K | 0.02% | 656 |
|
2025
Q1 | $2.42M | Sell |
34,280
-3,400
| -9% | -$240K | 0.02% | 586 |
|
2024
Q4 | $2.48M | Sell |
37,680
-2,275
| -6% | -$150K | 0.02% | 580 |
|
2024
Q3 | $2.81M | Sell |
39,955
-1,367
| -3% | -$96.1K | 0.02% | 708 |
|
2024
Q2 | $3.4M | Sell |
41,322
-4,730
| -10% | -$389K | 0.02% | 644 |
|
2024
Q1 | $4.02M | Buy |
46,052
+4,487
| +11% | +$392K | 0.03% | 634 |
|
2023
Q4 | $4.01M | Sell |
41,565
-3,690
| -8% | -$356K | 0.03% | 592 |
|
2023
Q3 | $4M | Sell |
45,255
-4,350
| -9% | -$385K | 0.03% | 560 |
|
2023
Q2 | $4.3M | Buy |
49,605
+6,704
| +16% | +$581K | 0.03% | 572 |
|
2023
Q1 | $4.17M | Sell |
42,901
-5,004
| -10% | -$487K | 0.04% | 583 |
|
2022
Q4 | $4.96M | Buy |
47,905
+2,024
| +4% | +$209K | 0.04% | 530 |
|
2022
Q3 | $3.89M | Sell |
45,881
-10,087
| -18% | -$855K | 0.04% | 590 |
|
2022
Q2 | $4.64M | Sell |
55,968
-2,878
| -5% | -$238K | 0.04% | 572 |
|
2022
Q1 | $4.54M | Sell |
58,846
-7,161
| -11% | -$552K | 0.03% | 686 |
|
2021
Q4 | $5.83M | Buy |
66,007
+2,148
| +3% | +$190K | 0.03% | 622 |
|
2021
Q3 | $4.94M | Buy |
63,859
+997
| +2% | +$77.1K | 0.03% | 660 |
|
2021
Q2 | $5.25M | Sell |
62,862
-2,131
| -3% | -$178K | 0.03% | 658 |
|
2021
Q1 | $4.91M | Buy |
64,993
+3,216
| +5% | +$243K | 0.03% | 635 |
|
2020
Q4 | $5.42M | Sell |
61,777
-46,553
| -43% | -$4.08M | 0.03% | 543 |
|
2020
Q3 | $8.24M | Sell |
108,330
-4,605
| -4% | -$350K | 0.06% | 341 |
|
2020
Q2 | $13.9M | Buy |
112,935
+8,418
| +8% | +$1.04M | 0.11% | 177 |
|
2020
Q1 | $8.83M | Sell |
104,517
-19,436
| -16% | -$1.64M | 0.09% | 239 |
|
2019
Q4 | $10.5M | Buy |
123,953
+10,079
| +9% | +$852K | 0.08% | 305 |
|
2019
Q3 | $7.68M | Sell |
113,874
-2,196
| -2% | -$148K | 0.06% | 405 |
|
2019
Q2 | $9.94M | Sell |
116,070
-6,266
| -5% | -$537K | 0.08% | 292 |
|
2019
Q1 | $10.9M | Buy |
122,336
+5,570
| +5% | +$495K | 0.09% | 258 |
|
2018
Q4 | $9.94M | Sell |
116,766
-6,341
| -5% | -$540K | 0.08% | 261 |
|
2018
Q3 | $11.9M | Sell |
123,107
-5,632
| -4% | -$546K | 0.08% | 296 |
|
2018
Q2 | $12.1M | Sell |
128,739
-3,663
| -3% | -$345K | 0.08% | 270 |
|
2018
Q1 | $10.7M | Buy |
132,402
+1,944
| +1% | +$158K | 0.03% | 656 |
|
2017
Q4 | $11.6M | Sell |
130,458
-17,699
| -12% | -$1.58M | 0.03% | 642 |
|
2017
Q3 | $13.8M | Buy |
148,157
+5,201
| +4% | +$484K | 0.03% | 580 |
|
2017
Q2 | $13M | Buy |
142,956
+3,163
| +2% | +$287K | 0.03% | 593 |
|
2017
Q1 | $12.3M | Buy |
139,793
+900
| +0.6% | +$79K | 0.03% | 609 |
|
2016
Q4 | $11.5M | Sell |
138,893
-7,848
| -5% | -$650K | 0.03% | 621 |
|
2016
Q3 | $13.6M | Sell |
146,741
-3,726
| -2% | -$345K | 0.04% | 581 |
|
2016
Q2 | $11.7M | Buy |
150,467
+455
| +0.3% | +$35.4K | 0.04% | 621 |
|
2016
Q1 | $12.4M | Sell |
150,012
-40,356
| -21% | -$3.33M | 0.04% | 641 |
|
2015
Q4 | $19.9M | Sell |
190,368
-22,865
| -11% | -$2.4M | 0.06% | 562 |
|
2015
Q3 | $22.5M | Buy |
213,233
+7,598
| +4% | +$800K | 0.07% | 510 |
|
2015
Q2 | $28.1M | Buy |
205,635
+19,747
| +11% | +$2.7M | 0.07% | 516 |
|
2015
Q1 | $23.2M | Buy |
185,888
+22,502
| +14% | +$2.8M | 0.05% | 603 |
|
2014
Q4 | $14.8M | Buy |
163,386
+9,941
| +6% | +$899K | 0.04% | 708 |
|
2014
Q3 | $11.1M | Buy |
153,445
+900
| +0.6% | +$64.9K | 0.03% | 843 |
|
2014
Q2 | $9.49M | Sell |
152,545
-20,826
| -12% | -$1.3M | 0.02% | 871 |
|
2014
Q1 | $11.8M | Buy |
173,371
+17,577
| +11% | +$1.2M | 0.03% | 799 |
|
2013
Q4 | $10.9M | Sell |
155,794
-3,778
| -2% | -$266K | 0.03% | 795 |
|
2013
Q3 | $11.5M | Sell |
159,572
-30,022
| -16% | -$2.17M | 0.04% | 776 |
|
2013
Q2 | $10.6M | Buy |
+189,594
| New | +$10.6M | 0.04% | 741 |
|